title: Combined effect of recombinant CD19 x CD16 diabody and thalidomide in a preclinical model of human B cell lymphoma.
authors.affiliation: University Hospital for Internal Medicine, Department of Hematology/Oncology, Heidelberg University Medical School, Heidelberg, Germany.
authors.forename: Jana
authors.initials: J
authors.lastname: Schlenzka
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Moehler
authors.forename: Sergey M
authors.initials: SM
authors.lastname: Kipriyanov
authors.forename: Martin
authors.initials: M
authors.lastname: Kornacker
authors.forename: Axel
authors.initials: A
authors.lastname: Benner
authors.forename: Alexandra
authors.initials: A
authors.lastname: Bähre
authors.forename: Marike J J G
authors.initials: MJ
authors.lastname: Stassar
authors.forename: Holger J
authors.initials: HJ
authors.lastname: Schäfer
authors.forename: Melvyn
authors.initials: M
authors.lastname: Little
authors.forename: Hartmut
authors.initials: H
authors.lastname: Goldschmidt
authors.forename: Björn
authors.initials: B
authors.lastname: Cochlovius
mesh_terms: D000818:Animals; D018033:Antibodies, Bispecific / Q000627:therapeutic use*; D018941:Antigens, CD19 / Q000276:immunology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D004353:Drug Evaluation, Preclinical; D004354:Drug Screening Assays, Antitumor / Q000379:methods; D006131:Growth Inhibitors / Q000494:pharmacology; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy* / Q000473:pathology*; D051379:Mice; D008807:Mice, Inbred BALB C; D016513:Mice, SCID; D017452:Receptors, IgG / Q000276:immunology*; D011994:Recombinant Proteins / Q000494:pharmacology; D013792:Thalidomide / Q000494:pharmacology*; D014407:Tumor Cells, Cultured; D023041:Xenograft Model Antitumor Assays / Q000379:methods
chemical_list: D018033:Antibodies, Bispecific; D018941:Antigens, CD19; D006131:Growth Inhibitors; D017452:Receptors, IgG; D011994:Recombinant Proteins; D013792:Thalidomide